Swiss based Pharma Veteran, Balasubramanian Srinivasan (Srini Srinivasan) joins TAKE Solutions Board as an Independent Director
- Global Pharma expert with 30+ years of experience
- Currently CEO, i3 Partners GmbH (Advisory in Healthcare), Switzerland
- Former Managing Director, Pfizer Healthcare India
- Former Chairman of the Board ZHOPL (JV of Pfizer and Zydus), India
- Former Global Head Commercial Strategy & Operations, Novartis, Switzerland
- Managed and maximized value of innovative products, vaccines and generics across multiple therapy areas like Oncology, Cardiovascular & Metabolism etc.,
Chennai, November 06, 2019: TAKE Solutions Ltd. [BSE: 532890 | NSE: TAKE], a globally recognized domain intensive services provider in Life Sciences, today announced the appointment of Srini Srinivasan as an Independent Director in TAKE Solutions Board of Directors.
Srini Srinivasan has over three decades of experience at Pfizer, Novartis, GSK and Astra in global leadership roles in General Management, Commercial, R&D and Manufacturing. He has led global cross-functional teams and launched brands in both Specialty and Primary Care across numerous therapeutic areas – Respiratory, Cardiovascular, Metabolism, Neuroscience, Infectious Diseases, Oncology and Immunology. He is an advisor to American Society of Clinical Oncology’s Cancer LinQ.
Srinivasan H R, Vice Chairman and Managing Director, TAKE Solutions said, “We are delighted to welcome Srini Srinivasan as his extensive experience in the Pharmaceuticals and Healthcare industry will further strengthen the Board. His addition is part of our ongoing commitment to best practice Corporate governance and ensuring we have a diversified Board capable of supporting the Company’s long-term strategic goals.”
He further added,” His substantial Global Pharma industry expertise will contribute to TAKE’s enabling appropriate strategy for Global markets.”
He lived and worked in Europe, USA, Asia Pacific and India. He holds a degree from Madras Medical College, an MBA from London Business School and received executive training at Harvard Business School.
